Undercurrent CapitalbetaSign in
Decrypt

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Read in Focus mode

TLDR — The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

Signal data─ Neutralconfidence 50%Low materiality
AssetEventsector-trendEvent timeAttention0 readers/hrNormalSmart readers0

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

0 impressions · 0 upvotes · 0 comments

Discussion (0)

Reading is open to everyone — posting, replying and reporting need an account.

Sign in to join the discussion

No comments yet.